Literature DB >> 27905214

The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.

Hasan Aydin Bas1, Fatih Aksoy2, Atilla Icli3, Ercan Varol4, Abdullah Dogan4, Dogan Erdogan4, Ibrahim Ersoy1, Akif Arslan4, Hatem Ari4, Nihal Bas5, Recep Sutcu6, Mehmet Ozaydin4.   

Abstract

Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST elevation myocardial infarction (STEMI). Oxidative stress and inflammation may cause structural and electrical remodeling in the atria making these critical processes in the pathology of AF. In this study, we aimed to evaluate the association between total oxidative status (TOS), total antioxidative capacity (TAC) and high-sensitivity C-reactive protein (hs-CRP) in the development of AF in patients presenting with STEMI. This prospective cohort study consisted of 346 patients with STEMI. Serum TAC and TOS were assessed by Erel's method. Patients were divided into two groups: those with and those without AF. Predictors of AF were determined by multivariate regression analysis. In the present study, 9.5% of patients developed AF. In the patients with AF, plasma TOS and oxidative stress index (OSI) values were significantly higher and plasma TAC levels were significantly lower compared to those without AF (p = .003, p = .002, p < .0001, respectively). Multivariate regression analysis results showed that, female gender (Odds ratio [OR] = 3.07; 95% Confidence Interval [CI] = 1.26-7.47; p = .01), left atrial diameter (OR =1.28; 95% CI =1.12-1.47; p < .0001), hs-CRP (OR =1.02; 95% CI =1.00-1.03; p = .001) and OSI (OR =1.10; 95% CI =1.04-1.18; p = .001) were associated with the development of AF in patients presenting with STEMI. The main finding of this study is that oxidative stress and inflammation parameters were associated with the development of AF in patients presenting with STEMI. Other independent predictors of AF were female gender, left atrial diameter and hs-CRP.

Entities:  

Keywords:  Antioxidants; atrial fibrillation; inflammation; myocardial infarction; oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27905214     DOI: 10.1080/00365513.2016.1244857

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

1.  Serum macrophage migration inhibitory factor is correlated with atrial fibrillation.

Authors:  Chunfu Wan; Zhihua Li
Journal:  J Clin Lab Anal       Date:  2017-04-13       Impact factor: 2.352

2.  Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation.

Authors:  Celestino Sardu; Gaetano Santulli; Matteo Santamaria; Michelangela Barbieri; Cosimo Sacra; Pasquale Paolisso; Fabio D'Amico; Nicola Testa; Igor Caporaso; Giuseppe Paolisso; Raffaele Marfella; Maria Rosaria Rizzo
Journal:  Am J Cardiol       Date:  2017-02-10       Impact factor: 2.778

3.  Telomere Length and Oxidative Stress in Patients with ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarction.

Authors:  Nihal Inandiklioğlu; Vahit Demir; Müjgan Ercan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function.

Authors:  Jorge Ortega-Hernández; Rashidi Springall; Fausto Sánchez-Muñoz; Julio-C Arana-Martinez; Héctor González-Pacheco; Rafael Bojalil
Journal:  BMC Cardiovasc Disord       Date:  2017-07-26       Impact factor: 2.298

5.  Inflammation-based Glasgow Prognostic Score in patients with acute ST-segment elevation myocardial infarction: A prospective cohort study.

Authors:  Yu Jia; Dongze Li; Yu Cao; Yisong Cheng; Lei Xiao; Yongli Gao; Lin Zhang; Zhi Zeng; Zhi Wan; Rui Zeng
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  The Impact of the Duration of Cardiac Troponin I Elevation on the Clinical Prognosis as Well as Incidence of New-Onset Atrial Fibrillation Respectively in Elderly Non-ST-Elevation Acute Myocardial Infarction Patients without PCI.

Authors:  Yu Wang; Xue-Dong Wang; Ji-Wen Yao; Bei-Bei Shi; Qing-Xiang Gu; Jing Zhang; Xiao-Ting Cui; Yan Wang
Journal:  J Inflamm Res       Date:  2021-12-15

Review 7.  Molecular mechanisms of sacubitril/valsartan in cardiac remodeling.

Authors:  Nor Hidayah Mustafa; Juriyati Jalil; Satirah Zainalabidin; Mohammed S M Saleh; Ahmad Yusof Asmadi; Yusof Kamisah
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

8.  The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation.

Authors:  Milan Pavlović; Svetlana Apostolović; Dragana Stokanović; Stefan Momčilović; Tatjana Jevtović-Stoimenov; Snezana Ćirić Zdravković; Sonja Šalinger Martinović; Nebojsa Krstić; Goran Koraćević; Danijela Djordjevic; Vladan Ćosić; Valentina N Nikolic
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

9.  Antioxidant and Anti-Inflammatory Effects of Curcumin Nanoparticles on Drug-Induced Acute Myocardial Infarction in Diabetic Rats.

Authors:  Paul-Mihai Boarescu; Ioana Boarescu; Ioana Corina Bocșan; Dan Gheban; Adriana Elena Bulboacă; Cristina Nicula; Raluca Maria Pop; Ruxandra-Mioara Râjnoveanu; Sorana D Bolboacă
Journal:  Antioxidants (Basel)       Date:  2019-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.